Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.40 |
| ▸ | DRD2 | P14416 | 1/20 | 0.39 |
| ▸ | DRD3 | P35462 | 1/20 | 0.39 |
| ▸ | GRIN1 | Q05586 | 4/20 | 0.39 |
| ▸ | GRIN2B | Q13224 | 4/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.37 |
| ▸ | NOS3 | P29474 | 1/20 | 0.36 |
| ▸ | NOS1 | P29475 | 1/20 | 0.36 |
| ▸ | NOS2 | P35228 | 1/20 | 0.36 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.36 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.36 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.35 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.35 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.35 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.35 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3991228 | 1.00 | TSHR (0.46) | TSHRACHEDRD2DRD3GRIN1 | |
| SCHEMBL13034003 | 1.00 | TSHR (0.46) | TSHRACHEDRD2DRD3GRIN1 | |
| SCHEMBL30731355 | 1.00 | TSHR (0.46) | TSHRACHEDRD2DRD3GRIN1 | |
| SCHEMBL29811187 | 1.00 | TSHR (0.46) | TSHRACHEDRD2DRD3GRIN1 | |
| SCHEMBL1276776 | 1.00 | TSHR (0.46) | TSHRACHEDRD2DRD3GRIN1 | |
| SCHEMBL30022542 | 0.98 | TSHR (0.44) | TSHRACHEDRD2DRD3GRIN1 | |
| SCHEMBL29405362 | 0.98 | TSHR (0.48) | TSHRACHEDRD2DRD3GRIN1 | |
| SCHEMBL26989 | 0.98 | TSHR (0.48) | TSHRACHEDRD2DRD3GRIN1 | |
| Ammonia Solution, Strong SCHEMBL28532522 | 0.96 | TSHR (0.42) | TSHRACHEDRD2DRD3GRIN1 | |
| Hydrochloric Acid SCHEMBL5058971 | 0.95 | TSHR (0.46) | TSHRACHEDRD2DRD3GRIN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 204 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105884574-B | A kind of method to methoxy-benzyl protection group of eliminating hydroxide | 浙江工业大学 | 2018-04-13 | — | — | CN | claimed |
| US-20090325992-A1 | COMPOUND HAVING CYCLIC GROUP BOUND THERETO THROUGH SPIRO BINDING AND USE THEREOF | ONO PHARMACEUTICAL CO., LTD. (JP) | 2009-12-31 | — | — | US | claimed |
| EP-2055705-A1 | COMPOUND HAVING CYCLIC GROUP BOUND THERETO THROUGH SPIRO BINDING AND USE THEREOF | Ono Pharmaceutical CO., LTD. (JP) | 2009-05-06 | — | — | EP | claimed |
| US-20070123510-A1 | Guanidine derivatives | ACTELION PHARMACEUTICALS LTD. (CH) | 2007-05-31 | — | — | US | claimed |
| US-6271400-B2 | SILICON BASED ANHYDROUS OXIDANT; LIGAND; CATALYTIC ORGANO OR INORGANO RHENIUM OXIDE; CONTROLLING EXCESS WATER CONCENTRATION AND MAXIMIZING MONOPEROXOCOMPLEX FORMATION. | THE SCRIPPS RESEARCH INSTITUTE | 2001-08-07 | — | — | US | claimed |
| US-20010001798-A1 | EPOXIDATION OF OLEFINS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2001-05-24 | — | — | US | claimed |
| US-5939568-A | Accelerated catalysis of olefinic epoxidations | THE SCRIPPS RESEARCH INSTITUTE (US) | 1999-08-17 | — | — | US | claimed |
| WO-1998033786-A1 | ACCELERATED CATALYSIS OF OLEFINIC EPOXIDATIONS | THE SCRIPPS RESEARCH INSTITUTE (US) | 1998-08-06 | — | — | WO | claimed |
| EP-4741436-A1 | POLYMERIZABLE COMPOSITION FOR OPTICAL MATERIAL, POLYMERIZABLE PREPOLYMER COMPOSITION FOR OPTICAL MATERIAL, CURED ARTICLE, AND METHOD FOR PRODUCING OPTICAL MATERIAL | Mitsui Chemicals, Inc. (JP) | 2026-05-13 | — | — | EP | disclosed |
| US-12281062-B2 | Light induced catalytic C—H oxygenation of alkanes | Ariel Scientific Innovations Ltd. (IL) | 2025-04-22 | — | — | US | disclosed |
| WO-2025041800-A1 | POLYMERIZABLE COMPOSITION FOR OPTICAL MATERIAL, POLYMERIZABLE PREPOLYMER COMPOSITION FOR OPTICAL MATERIAL, CURED ARTICLE, AND METHOD FOR PRODUCING OPTICAL MATERIAL | 三井化学株式会社 | 2025-02-27 | — | — | WO | disclosed |
| CN-117050219-B | Preparation method and application of pyridocycloheptane imine iron complex catalyst | 桂林理工大学 | 2024-07-23 | — | — | CN | disclosed |
| WO-2024096030-A1 | METHOD FOR PRODUCING OPTICAL MEMBER, AND THERMAL INSULATION MEMBER | 三井化学株式会社 | 2024-05-10 | — | — | WO | disclosed |
| US-20240150293-A1 | SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS | VERNALIS (R&D) LTD (GB) | 2024-05-09 | — | — | US | disclosed |
| US-4762843-A | Hetero [f] fused carbocyclic pyridines as dopaminergic agents | WARNER-LAMBERT COMPANY (US) | 1988-08-09 | — | — | US | disclosed |
| EP-0260642-A2 | Thiazolo [f]-fused hexahydroquinoline derivatives as dopaminergic agents | WARNER-LAMBERT COMPANY (US) | 1988-03-23 | — | — | EP | disclosed |
| EP-0203722-A1 | Bicyclic pyrazolidinones | ELI LILLY AND COMPANY (US) | 1986-12-03 | — | — | EP | disclosed |
| EP-0202046-A1 | 7-Substituted bicyclic pyrazolidinones | ELI LILLY AND COMPANY (US) | 1986-11-20 | — | — | EP | disclosed |
| US-4332940-A | DEHYDRATION OR DEHYDROGENATION MIXED OXIDE CATALYST | DEUTSCHE GOLD -UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DE) | 1982-06-01 | — | — | US | disclosed |
| US-4168311-A | APHIDICIDES | HOECHST AKTIENGESELLSCHAFT (DE) | 1979-09-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240150293-A1 | SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS | BCL2, BAX, BCL2A1 | TSHR 2897/4885ACHE 4262/4885DRD2 2887/4885 |
| US-20070123510-A1 | Guanidine derivatives | NPFFR1, NPFFR2, OGFR | TSHR 669/4885ACHE 548/4885DRD2 202/4885 |
| US-20090325992-A1 | COMPOUND HAVING CYCLIC GROUP BOUND THERETO THROUGH SPIRO BINDING AND USE THEREOF | CXCR4, CXCL12, CXCR1 | TSHR 1517/4885ACHE 3735/4885DRD2 2452/4885 |
| US-12281062-B2 | Light induced catalytic C—H oxygenation of alkanes | CBR1, CBR3, HAO2 | TSHR 4578/4885ACHE 2357/4885DRD2 829/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.